Search research articles
Contact Us
Filters
Showing results (191-200 of 301) with videos related to
Page
of 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures
James Chambers, Elle Pope, Kathy Bungay, et al.
Journal of Managed Care Pharmacy : JMCP
|
March 31, 2009
Standardizing quality assessment of observational studies for decision making in health care
Diana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Melanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.
The American Journal of Managed Care
|
October 18, 2019
Variation in US private health plans' coverage of orphan drugs
James D Chambers, Ari D Panzer, David D Kim, et al.
Radiology
|
June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer disease
Pamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Headache
|
August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment
Jeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.
The American Journal of Managed Care
|
April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare system
Peter J Neumann, Jennifer A Palmer, Norman Daniels, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Page
of 31
Search research articles
Search
Showing results (191-200 of 301) with videos related to
Sort By:
Page
of 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures
James Chambers, Elle Pope, Kathy Bungay, et al.
Journal of Managed Care Pharmacy : JMCP
|
March 31, 2009
Standardizing quality assessment of observational studies for decision making in health care
Diana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses
Melanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.
The American Journal of Managed Care
|
October 18, 2019
Variation in US private health plans' coverage of orphan drugs
James D Chambers, Ari D Panzer, David D Kim, et al.
Radiology
|
June 13, 2003
Cost-effectiveness of PET in the diagnosis of Alzheimer disease
Pamela M McMahon, Sally S Araki, Eileen A Sandberg, et al.
Health Affairs (Project Hope)
|
November 5, 2019
Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage
James D Chambers, Ari D Panzer, Elle F Pope, et al.
Headache
|
August 20, 2005
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment
Jeffrey S Brown, George Papadopoulos, Peter J Neumann, et al.
The American Journal of Managed Care
|
April 12, 2008
A strategic plan for integrating cost-effectiveness analysis into the US healthcare system
Peter J Neumann, Jennifer A Palmer, Norman Daniels, et al.
Health Affairs Scholar
|
February 25, 2026
FDA approvals of specialty drugs, 2000-2024
Sophie E Knox, Claire H Brennan, Daniel E Enright, et al.
Health Affairs Scholar
|
July 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?
Molly T Beinfeld, Fariel LaMountain, Glenn Phillips, et al.
Page
of 31